1   
Release Date Title (Click to read)
May 15, 2012 Pernix Therapeutics Reports First Quarter 2012 Financial Results
May 15, 2012 Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio
May 9, 2012 Pernix Therapeutics to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
May 7, 2012 Pernix Therapeutics to Report First Quarter 2012 Financial Results on May 15, 2012
Apr 26, 2012 Pernix Therapeutics Completes At-the-Market Equity Offering
Mar 29, 2012 Pernix Therapeutics to Present at the 11th Annual Needham Healthcare Conference
Mar 28, 2012 Pernix Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results
Mar 21, 2012 Pernix Therapeutics to Report Fourth Quarter and Full Year 2011 Financial Results on March 28, 2012
Mar 7, 2012 Pernix Therapeutics Provides Business Update and Announces New Product Development Agreement
Mar 6, 2012 Pernix Therapeutics to Present at the 24th Annual ROTH Conference
Feb 28, 2012 Pernix Therapeutics to Present at the Cowen and Company 32nd Annual Health Care Conference
Jan 23, 2012 Pernix Therapeutics Announces Agreement to License a New FDA-Approved Product to Treat Gastroenterology Disease
Dec 6, 2011 Pernix Therapeutics Expands Senior Management Team to Support Continued Business Growth
Nov 21, 2011 Pernix Therapeutics to Present at the Piper Jaffray 23rd Annual Health Care Conference
Nov 15, 2011 Pernix Therapeutics Holdings Reports Third Quarter 2011 Financial Results
Aug 31, 2011 Pernix Therapeutics Appoints Steven A. Elms to Board of Directors
Aug 24, 2011 Pernix Therapeutics to Present at the Stifel Nicolaus Healthcare Conference
Aug 16, 2011 Pernix Therapeutics Holdings Reports Second Quarter 2011 Financial Results
Aug 15, 2011 Pernix Therapeutics and ParaPRO Announce Commercial Launch of Natroba™ For Treatment of Head Lice
Aug 3, 2011 Pernix Therapeutics Holdings to Report Second Quarter 2011 Financial Results on August 16, 2011
 1